Contributors: Swiss IBD Cohort Study Group; Anderegg, C.; Bauerfeind, P.; Beglinger, C.; Begré, S.; Belli, D.; Bengoa, J.M.; Biedermann, L.; Bigler, B.; Binek, J.; Blattmann, M.; Boehm, S.; Borovicka, J.; Braegger, C.P.; Brunner, N.; Bühr, P.; Burnand, B.; Burri, E.; Buyse, S.; Cremer, M.; Criblez, D.H.; de Saussure, P.; Degen, L.; Delarive, J.; Doerig, C.; Dora, B.; Dorta, G.; Egger, M.; Ehmann, T.; El-Wafa, A.; Engelmann, M.; Ezri, J.; Felley, C.; Fliegner, M.; Fournier, N.; Fraga, M.; Frei, P.; Frei, R.; Fried, M.; Froehlich, F.; Funk, C.; Furlano, R.I.; Gallot-Lavallée, S.; Geyer, M.; Girardin, M.; Golay, D.; Grandinetti, T.; Gysi, B.; Haack, H.; Haarer, J.; Helbling, B.; Hengstler, P.; Herzog, D.; Hess, C.; Heyland, K.; Hinterleitner, T.; Hiroz, P.; Hirschi, C.; Hruz, P.; Iwata, R.; Jost, R.; Juillerat, P.; Brondolo, V.K.; Knellwolf, C.; Knoblauch, C.; Köhler, H.; Koller, R.; Krieger-Grübel, C.; Kullak-Ublick, G.; Künzler, P.; Landolt, M.; Lange, R.; Lehmann, F.S.; Macpherson, A.; Maerten, P.; Maillard, M.H.; Manser, C.; Manz, M.; Marbet, U.; Marx, G.; Matter, C.; McLin, V.; Meier, R.; Mendanova, M.; Meyenberger, C.; Michetti, P.; Misselwitz, B.; Moradpour, D.; Morell, B.; Mosler, P.; Mottet, C.; Müller, C.; Müller, P.; Müllhaupt, B.; Münger-Beyeler, C.; Musso, L.; Nagy, A.; Neagu, M.; Nichita, C.; Niess, J.; Noël, N.; Nydegger, A.; Obialo, N.; Oneta, C.; Oropesa, C.; Peter, U.; Peternac, D.; Petit, L.M.; Piccoli-Gfeller, F.; Pilz, J.B.; Pittet, V.; Raschle, N.; Rentsch, R.; Restellini, S.; Richterich, J.P.; Rihs, S.; Ritz, M.A.; Roduit, J.; Rogler, D.; Rogler, G.; Rossel, J.B.; Sagmeister, M.; Saner, G.; Sauter, B.; Sawatzki, M.; Schäppi, M.; Scharl, M.; Schelling, M.; Schibli, S.; Schlauri, H.; Uebelhart, S.S.; Schnegg, J.F.; Schoepfer, A.; Seibold, F.; Seirafi, M.; Semadeni, G.M.; Semela, D.; Senning, A.; Sidler, M.; Sokollik, C.; Spalinger, J.; Spangenberger, H.; Stadler, P.; Steuerwald, M.; Straumann, A.; Straumann-Funk, B.; Sulz, M.; Thorens, J.; Tiedemann, S.; Tutuian, R.; Vavricka, S.; Viani, F.; Vögtlin, J.; Von Känel, R.; Vonlaufen, A.; Vouillamoz, D.; Vulliamy, R.; Wermuth, J.; Werner, H.; Wiesel, P.; Wiest, R.; Wylie, T.; Zeitz, J.; Zimmermann, D.; University of Zurich; Misselwitz, Benjamin
نبذة مختصرة : Background Abdominal pain is a frequent symptom in patients with inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC). Pain can result from ongoing inflammation or functional disorders imitating irritable bowel syndrome (IBS). Several single-nucleotide polymorphisms (SNPs) have been associated with IBS. However, the impact of IBS genetics on the clinical course of IBD, especially pain levels of patients remains unclear. Methods Data of 857 UC and 1206 CD patients from the Swiss IBD Cohort Study were analysed. We tested the association of the maximum of the abdominal pain item of disease activity indices in UC and CD over the study period with 16 IBS-associated SNPs, using multivariate ANOVA models. Results In UC patients, the SNPs rs1042713 (located on the ADRB2 gene) and rs4663866 (close to the HES6 gene) were associated with higher abdominal pain levels (P = 0.044; P = 0.037, respectively). Abdominal pain was not associated with any markers of patient management in a model adjusted for confounders. In CD patients, higher levels of abdominal pain correlated with the number of physician contacts (P
BMC Gastroenterology, 21 (1)
ISSN:1471-230X
Processing Request
No Comments.